OTC Pharmaceuticals - Eastern Africa

The revenue generated in the OTC Pharmaceuticals market in 2024 in Eastern Africa amounts to US$1.50bn.
It is projected that the market will experience an annual growth rate of 8.09% (CAGR 2024-2029).
The largest market within the OTC Pharmaceuticals market is Vitamins & Minerals, with a market volume of US$452.90m in 2024.
In comparison to other countries globally, the United States generates the highest revenue in the OTC Pharmaceuticals market, reaching US$41.24bn in 2024.
When considering the total population figures, it can be observed that per person revenues amount to US$3.28 in 2024.
Looking ahead to 2024, it is estimated that 2.05% of the total revenue in the OTC Pharmaceuticals market will be generated through online sales.
Eastern Africa's OTC pharmaceutical market is witnessing a growing demand for herbal remedies, reflecting a preference for natural and traditional healthcare solutions.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Eastern Africa is experiencing steady growth due to increasing customer preferences for self-medication, a rising middle class, and the presence of local special circumstances. Customer preferences in Eastern Africa are shifting towards self-medication, driven by factors such as convenience, cost-effectiveness, and the availability of a wide range of OTC products. Consumers are increasingly seeking remedies for common ailments such as headaches, colds, and allergies without the need for a prescription. This trend is further fueled by the growing awareness and accessibility of information through digital platforms, enabling consumers to research and select the most suitable OTC products for their needs. Trends in the market indicate a growing demand for OTC pharmaceuticals in Eastern Africa. The region's rising middle class has greater disposable income and is willing to spend on healthcare products, including OTC medications. As the population becomes more urbanized and lifestyles become more sedentary, there is an increasing incidence of lifestyle-related diseases such as obesity, diabetes, and hypertension. This has led to a higher demand for OTC products that address these conditions. Additionally, the ongoing COVID-19 pandemic has heightened awareness of health and hygiene, leading to increased sales of OTC products such as hand sanitizers, disinfectants, and immune boosters.Local special circumstances in Eastern Africa contribute to the development of the OTC Pharmaceuticals market. The region has a fragmented healthcare system with limited access to healthcare facilities, especially in rural areas. This lack of access to healthcare services drives individuals to seek self-care options through OTC medications. Furthermore, the high cost of prescription drugs and the long waiting times at healthcare facilities also encourage consumers to opt for OTC products as an affordable and convenient alternative.Underlying macroeconomic factors also play a role in the growth of the OTC Pharmaceuticals market in Eastern Africa. The region has been experiencing steady economic growth, leading to an expansion of the middle class and increased purchasing power. This economic growth has also attracted multinational pharmaceutical companies to invest in the region, expanding the availability and accessibility of OTC products. Additionally, governments in Eastern Africa are increasingly recognizing the importance of self-care and are implementing policies to promote the use of OTC medications. This includes initiatives to educate the public about the safe and responsible use of OTC products.In conclusion, the OTC Pharmaceuticals market in Eastern Africa is developing due to customer preferences for self-medication, a rising middle class, local special circumstances, and underlying macroeconomic factors. As consumers continue to seek convenience and cost-effective healthcare solutions, the demand for OTC medications is expected to grow in the region.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.